Kiniksa Pharmaceuticals International, plc (KNSA) /

The debt of Kiniksa Pharmaceuticals International, plc over the past 9 years

Chart Kiniksa Pharmaceuticals International, plc: liquid cash, total debt, net cash, fiscal 2017–2025 Open the chart →

At the end of fiscal 2025, the latest fiscal year on file, Kiniksa Pharmaceuticals International, plc had liquid cash of $414.07M and total debt of $0: net cash of $414.07M. It had more liquid cash than debt at all 9 year-ends shown.

Year by year

Fiscal yearLiquid cashTotal debt*Net cash*
2025ended Dec 31, 2025$414.07M*$0$414.07M
2024ended Dec 31, 2024$243.63M*$0$243.63M
2023ended Dec 31, 2023$206.37M*$0$206.37M
2022ended Dec 31, 2022$190.61M*$0$190.61M
2021ended Dec 31, 2021$182.2M*$0$182.2M
2020ended Dec 31, 2020$323.48M*$0$323.48M
2019ended Dec 31, 2019$233.38M*$0$233.38M
2018ended Dec 31, 2018$307.3M*$0$307.3M
2017ended Dec 31, 2017$45.55M$0$45.55M

Fiscal years as Kiniksa Pharmaceuticals International, plc reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.

More on Kiniksa Pharmaceuticals International, plc

Companies of a similar size

Not investment advice. This page shows what Kiniksa Pharmaceuticals International, plc filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.